Edgar Overton

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (5)

Todd T Brown

Johns Hopkins University

UNITED STATES

View details

Carlos Malvestutto

Associate Professor

The Ohio State University Wexner Medical Center

UNITED STATES

View details

Judith Currier

Professor

University of California, Los Angeles

UNITED STATES

View details

Kristine M. Erlandson

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Jacqueline Flynn

Thomas Jefferson University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Edgar Overton

Research Interests

Explore related searches

Contact this professor

Articles (20)

APOL1 Genotype and HIV Infection: 20-Year Outcomes for CKD, Cardiovascular Disease, and Hypertension

Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function

Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV

Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV

Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV

Risk factors for progression from prediabetes to diabetes among older people with HIV

Association of Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy With Blood Pressure and Sustained Hypertension in People With Human Immunodeficiency Virus

Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations

What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?

Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial

Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)

Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes

Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study

Hypertension and Cardiovascular Disease Risk Among Individuals With Versus Without HIV

Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV

Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV).

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States

Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy

Collaborators (5)

Todd T Brown

Carlos Malvestutto

Judith Currier

Kristine M. Erlandson

Jacqueline Flynn

Make your next move.